A Study of Obexelimab in Patients With Relapsing Multiple Sclerosis (MoonStone)
A Study of Obexelimab in Patients With Relapsing Multiple Sclerosis (MoonStone)
Active, not recruiting · NCT06564311 · Registry updated 2025-11-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Obexelimab in Patients With Relapsing Multiple Sclerosis (MoonStone) | CNS demyelinating autoimmune disease, autoimmune disease, autoimmune disorder of the nervous system, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder | Active, not recruiting | Phase 2 | 2025-11-17 | NCT06564311 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Zenas BioPharma (USA), LLC | 6 |
47 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.